MAR 17, 2015 11:22 AM PDT

Are Psychedelics the New Wonder Drugs?

WRITTEN BY: Robert Woodard
Ruby slippers LSD sheetA recent article in Forbes discusses new research findings that point toward a shift in perception about psychedelic drugs.

The idea that psychedelics cause psychosis has a long history in urban mythology. In the 1980s, the story was that "seven hits of acid make you legally insane."

Of course, the number fluctuated through the years, but the core idea-drugs like LSD and psilocybin are dangerous to our long term mental health-remained a constant.

Now the story is changing.

Two new studies have found no link between psychedelic use and a wide suite of mental health conditions, including schizophrenia, psychosis, depression, anxiety disorders and suicide attempts.

The first, conducted by researchers from the Norwegian University of Science, made use of the copious data compiled by US National Survey of Drug Use and Health. By examining answers from 135,000 people who took the survey between 2008 and 2011, the researchers identified their core study group-the 14 percent of survey-takers who said they had used any of the three classic psychedelics (acid, mushrooms, or peyote) at some point in their lives.

Working backwards, they discovered that psychedelic-users were not at an increased risk of developing eleven key indicators of serious mental health problems.

A second study done at the University of Alabama and Johns Hopkins confirmed this finding. This study used the National Survey as core data, but examined responses from 2008 to 2012. Here too, the researchers involved also found no causal relationship between the three classic psychedelics and long-term mental health problems.

But where this second study gets even more interesting is that the researchers then inverted their line of questioning and went looking for positive mental health developments. And they found them. People who had tried LSD or psilocybin had lower lifetime rates of suicidal thoughts and attempts.

Source: forbes.com
About the Author
You May Also Like
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
How close are we to a simple blood test for Parkinson's Disease?
Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness”...
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
Researchers Grow Psilocybin from E. Coli Bacteria
Previously considered to be narcotic, and under tight regulation as an illicit drug for decades, research from recent years on the possible medicinal prope...
JAN 06, 2020
Cardiology
JAN 06, 2020
Online Therapy Treats Depression in Heart Disease Patients
People suffering from cardiovascular disease (CVD) often suffer from depression too- something that can lead to a vicious cycle in which CVD can be negativ...
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked to a lower risk of developing Alzhei...
FEB 10, 2020
Cell & Molecular Biology
FEB 10, 2020
Lighting a Path to an Alzheimer's Disease Treatment
Alzheimer's impacts millions of people around the world; globally, it is thought to cost $605 billion a year, and there is still no way to treat it....
Loading Comments...